Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 41 ~ 60 of 25905, Page 3 of 1296
41. Radiology Publishes Roadmap for AI in Medical Imaging
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA), the American College of Radiology (ACR) and The Academy for Radiology and Biomedical Imaging Research (The Academy). The organizers aimed to foster collaboration in applications for diagnostic medical imaging, identify knowledge gaps and develop a roadmap to prioritize research needs. The group''s research roadmap was published today as a special report in the journal Radiology.
04/16/2019 Radiological Society of North America
42. FDA Approves First Targeted Therapy for Bladder Cancer
The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
04/16/2019 American Cancer Society
43. FDA Statement from Deputy Commissioner for Food Policy and Response Frank Yiannas on new steps to protect consumers from unlawful ingredients in dietary supplements
04/16/2019 U.S. FOOD & DRUG ADMINISTRATION
44. FDA Warns of Cancer Risk in a Type of Uterine Fibroid Surgery
The US Food and Drug Administration (FDA) is warning women and doctors about the risks of a certain technique used in surgery for uterine fibroids.
04/15/2019 American Cancer Society
45. At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices
WHO to continue to facilitate countries' information-sharing to improve transparency on prices
04/13/2019 WHO
46. Results of Phase 3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam) versus Meropenem for Treatment of Adult Patients with Ventilated Nosocomial Pneumonia (VNP) to be Presented at ECCMID 2019
ASPECT-NP Clinical Trial Results Demonstrated Non-Inferiority of ZERBAXA to Meropenem for Treating Ventilated Nosocomial Pneumonia in Primary and Key Secondary Endpoints
04/13/2019 MERCK
47. FDA approves first targeted therapy for metastatic bladder cancer
04/12/2019 U.S. FOOD & DRUG ADMINISTRATION
48. Statement from Jeff Shuren, M.D., director of the Center for Devices and Radiological Health, on agency efforts to mitigate temporary shortage of pediatric breathing tubes due to recent closure of Illinois sterilization facility
04/12/2019 U.S. FOOD & DRUG ADMINISTRATION
49. Statement from Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on continued efforts to assess duodenoscope contamination risk
04/12/2019 U.S. FOOD & DRUG ADMINISTRATION
50. Diet, Exercise, and Your Cancer Risk
Two of the most important lifestyle habits to help you lower your cancer risk are eating healthy and staying active. Learn about cancer’s connection to diet and exercise.
04/12/2019 American Cancer Society
51. FDA orders important safety labeling changes for Addyi
04/11/2019 U.S. FOOD & DRUG ADMINISTRATION
52. Nation’s Ophthalmologists Push to Remove Roadblocks to Patients’ Access to Medical and Surgical Eye Care
The American Academy of Ophthalmology’s annual visit to Capitol Hill emphasizes need to maintain the highest quality of care for patients.
04/11/2019 American Academy of Ophthalmology
53. FDA Approves Expanded Monotherapy Label for Merck’s KEYTRUDA® (pembrolizumab)
KEYTRUDA Now Approved for First-Line Treatment of Patients with Stage III NSCLC Who Are Not Candidates for Surgical Resection or Definitive Chemoradiation, or Metastatic NSCLC, and Whose Tumors Express PD-L1 (TPS ≥1%), with No EGFR or ALK Genomic Tumor Aberrations
04/11/2019 MERCK
54. Survivor of Pancreatic Neuroendocrine Tumor Finds Comfort in Music
Tom Bajoras says he’s written some of his best music during nights when pain kept him from sleeping. Bajoras has been playing and writing music since he was a child, and he’s found the creative process helpful during treatment for a pancreatic neuroendocrine tumor (NET).
04/11/2019 American Cancer Society
55. High-strength MRI Tracks MS Progression
Research suggests a role for ultra-high-field-strength MRI in evaluating the progression of MS. / Twenty-five of the MS patients in the study developed new cortical lesions. / Volume of cortical lesions was a predictor of neurological disability.
04/09/2019 Radiological Society of North America
56. AAEM Announces 2019 Board of Directors Election Results
MILWAUKEE ? The American Academy of Emergency Medicine (AAEM) is pleased to announce that Luis E. Gomez, Sr., MD MBA FAAEM and Carol Pak-Teng, MD FAAEM were elected to two-year terms as at-large board members.
04/08/2019 American Academy of Emergency Medicine
57. Statement on FDA’s ongoing scientific investigation of potential safety issue related to seizures reported following e-cigarette use, particularly in youth and young adults
04/03/2019 U.S. FOOD & DRUG ADMINISTRATION
58. Statement on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk, while progressing the agency’s commitment to help advance legitimate stem cell product development under existing agency regulations
04/03/2019 U.S. FOOD & DRUG ADMINISTRATION
59. ACS Report: More Effort Needed to Reduce Cancer Risk in the US
avoiding tobacco, staying at a healthy weight, eating a healthy diet, limiting alcohol, getting enough physical activity, and getting recommended screenings and vaccinations
04/03/2019 American Cancer Society
60. 1 in 4 health care facilities lacks basic water services ? UNICEF, WHO
04/03/2019 WHO
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱